Update on mcr-1 gene in the United States

["Centers for Disease Control and Prevention (CDC)" <cdc@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: Update on mcr-1 gene in the United States

Update on mcr-1 gene in the United States

CDC released two reports today describing patients with bacteria containing the mcr-1 gene. The mcr-1 gene can make bacteria resistant to the antibiotic colistin, a crucial last-resort drug for some life-threatening, multidrug-resistant infections. The gene also has the potential to spread quickly to other bacteria. The reports describe patients from Pennsylvania and Connecticut and the public health investigation that followed.

The mcr-1 gene was first reported in China in November of 2015. Since that time, CDC and federal partners have been searching for the mcr-1 gene in bacteria in the United States. The discovery of the mcr-1 gene illustrates domestic and global challenges around antibiotic resistance. The reports today also emphasizes the importance of a coordinated public health response.  

Learn more:

• Investigation of First Identified mcr-1 Gene in an Isolate from a U.S. Patient — Pennsylvania, 2016
• Investigation of Escherichia coli Harboring the mcr-1 Resistance Gene — Connecticut, 2016
• Tracking mcr-1 gene in the U.S. and data used to create the U.S. tracking map.
• Investments in CDC’s Antibiotic Resistance Solutions Initiative.

The CDC has reached over 1.2 million email subscribers. Thank you for your support.

Modify/Update Subscriber Preferences or Unsubscribe | Learn about CDC Updates

Questions or problems? Please contact support@xxxxxxxxxxxxxxx.

   

       

---

This email was sent to list-cdc@xxxxxxxxxxx using GovDelivery,on behalf of: Centers for Disease Control and Prevention • 1600 Clifton Rd • Atlanta, GA 30333 • 1-800-CDC-INFO (800-232-4636)